2022 Q4 Form 10-K Financial Statement

#000147793223002609 Filed on April 17, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $5.750K $5.750K
YoY Change 5.31% 5.31%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $11.75K $13.36K
YoY Change 190.12% 137.05%
Operating Profit -$13.36K
YoY Change 137.05%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$11.75K -$13.36K
YoY Change 190.12% 136.88%
Income Tax
% Of Pretax Income
Net Earnings -$11.75K -$13.36K
YoY Change 190.12% 137.05%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 49.50M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $700.00 $700.00
YoY Change -13.58% -13.58%
Cash & Equivalents $702.00
Short-Term Investments
Other Short-Term Assets $3.490K $3.490K
YoY Change 0.0% 0.0%
Inventory
Prepaid Expenses $3.485K
Receivables $5.000K $5.000K
Other Receivables $40.00K $40.00K
Total Short-Term Assets $49.19K $49.19K
YoY Change 11.04% 11.04%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $300.5M $300.5M
YoY Change 0.0% 0.15%
TOTAL ASSETS
Total Short-Term Assets $49.19K $49.19K
Total Long-Term Assets $300.5M $300.5M
Total Assets $300.5M $300.5M
YoY Change 0.0% 0.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $4.000K $4.000K
YoY Change 0.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $300.0M $300.0M
YoY Change 0.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $300.1M $300.1M
YoY Change 0.0% 0.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $300.1M $300.1M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $300.1M $300.1M
YoY Change 0.0% 0.01%
SHAREHOLDERS EQUITY
Retained Earnings -$39.28M
YoY Change 0.03%
Common Stock $500.0K
YoY Change 1.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $439.4K $439.4K
YoY Change
Total Liabilities & Shareholders Equity $300.5M $300.5M
YoY Change 0.0% 0.15%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$11.75K -$13.36K
YoY Change 190.12% 137.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$12.50K -$12.61K
YoY Change -986.52% 6904.44%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.50K $0.00
YoY Change -956.16%
NET CHANGE
Cash From Operating Activities -12.50K -$12.61K
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities 12.50K $0.00
Net Change In Cash 0.000000000009095 -$108.00
YoY Change -100.0% -40.0%
FREE CASH FLOW
Cash From Operating Activities -$12.50K -$12.61K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000055234
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49504185 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50004185 shares
CY2021 kens Shares Issued In Settlement Of Debt Amount
SharesIssuedInSettlementOfDebtAmount
26858 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
0-08962
CY2022 dei Entity Registrant Name
EntityRegistrantName
KENILWORTH SYSTEMS CORPORATION
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1641415
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
721 Beach Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Daytona Beach
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32114
CY2022 dei City Area Code
CityAreaCode
312
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
300499198 usd
CY2022 dei Local Phone Number
LocalPhoneNumber
372-6900
CY2022 dei Security12g Title
Security12gTitle
Common Stock, par value $.01 per share
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
589259 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49504185 shares
CY2022 dei Auditor Firm
AuditorFirmId
5968
CY2022 dei Auditor Name
AuditorName
OLAYINKA OYEBOLA & CO.
CY2022 dei Auditor Location
AuditorLocation
Lagos Nigeria
CY2022Q4 us-gaap Cash
Cash
702 usd
CY2021Q4 us-gaap Cash
Cash
810 usd
CY2022Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
40000 usd
CY2021Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
40000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3485 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3485 usd
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
5000 usd
CY2021Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
49187 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
44295 usd
CY2022Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
30000000 usd
CY2021Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
30000000 usd
CY2022Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
270450011 usd
CY2021Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
270450011 usd
CY2022Q4 us-gaap Assets
Assets
300499198 usd
CY2021Q4 us-gaap Assets
Assets
300494306 usd
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
4000 usd
CY2021Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
4000 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
48335 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
42585 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
300007500 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
300000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
300059835 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
300046585 usd
CY2022Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
0 usd
CY2021Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
0 usd
CY2022Q4 us-gaap Liabilities
Liabilities
300059835 usd
CY2021Q4 us-gaap Liabilities
Liabilities
300046585 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50004185 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49504185 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
500042 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
495042 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39219146 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39219146 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39279950 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39266592 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
439363 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
447721 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
300494306 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2022 kens Bank Charges Feesexpenses
BankChargesFeesexpenses
108 usd
CY2021 kens Bank Charges Feesexpenses
BankChargesFeesexpenses
180 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
5750 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
4000 usd
CY2022 kens Miscellaneous
Miscellaneous
7500 usd
CY2021 kens Miscellaneous
Miscellaneous
0 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
13358 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
4180 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-13358 usd
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4180 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13358 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4180 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0003
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
25043 usd
CY2021 kens Common Stock Issued For Acquisition Of Assets Amount
CommonStockIssuedForAcquisitionOfAssetsAmount
400000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4180 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
447721 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
447721 usd
CY2022 kens Common Stock Issued During The Year Amount
CommonStockIssuedDuringTheYearAmount
5000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13358 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
439363 usd
CY2022 us-gaap Profit Loss
ProfitLoss
13358 usd
CY2021 us-gaap Profit Loss
ProfitLoss
4180 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2021 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 kens Common Stock Issued For Services
CommonStockIssuedForServices
0 usd
CY2021 kens Common Stock Issued For Services
CommonStockIssuedForServices
0 usd
CY2022 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
5000 usd
CY2021 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
42585 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
5750 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
46585 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12608 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-180 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
12500 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-108 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-180 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
810 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
990 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
702 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
810 usd
CY2021Q3 kens Common Stock Unissued Par Value
CommonStockUnissuedParValue
0.01
CY2022 kens Common Stocks Issued In Acquisition
CommonStocksIssuedInAcquisition
40000000 shares
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.   Actual results could differ from those estimates.</p>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
702 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13358 usd
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
300000000 usd
CY2021Q3 kens Maturity Date
MaturityDate
September 28, 2022
CY2021Q3 us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.05 pure
CY2021Q3 kens Registrant S Authorized Shares
RegistrantSAuthorizedShares
40000000 shares
CY2021Q3 kens Common Stock Unissued Par Value
CommonStockUnissuedParValue
0.01
CY2021Q3 kens Registrant S Authorized Shares
RegistrantSAuthorizedShares
40000000 shares
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000000 usd
CY2022 us-gaap Stock Issued1
StockIssued1
12375000000 usd

Files In Submission

Name View Source Status
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
0001477932-23-002609-index-headers.html Edgar Link pending
0001477932-23-002609-index.html Edgar Link pending
0001477932-23-002609.txt Edgar Link pending
0001477932-23-002609-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kenilworth_10k.htm Edgar Link pending
kenilworth_10kimg1.jpg Edgar Link pending
kenilworth_10kimg2.jpg Edgar Link pending
kenilworth_ex311.htm Edgar Link pending
kenilworth_ex312.htm Edgar Link pending
kenilworth_ex321.htm Edgar Link pending
kenilworth_ex322.htm Edgar Link pending
kens-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
kens-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
kens-20221231_def.xml Edgar Link unprocessable
kens-20221231_lab.xml Edgar Link unprocessable
kens-20221231_pre.xml Edgar Link unprocessable
kenilworth_10k_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending